Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05020496

Trem-1 and Ultraviolet Radiation-induced Immune Suppression

Conditions: Skin Diseases

Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: Yes
Phase: EARLY_PHASE1
Enrollment: 70
Sponsor: University of Alabama at Birmingham

Location: Whitaker Clinic Birmingham Alabama

Summary

The overall goal of this study is to determine novel mechanisms for ultraviolet light (UV)-induced suppression of the immune system in human subjects and to improve understanding of UV-induced skin carcinogenesis.

Eligibility Criteria

* Inclusion Criteria * Patient age 18-35 * Patient able to understand requirements of the study and risks involved * Patient able to sign a consent form Exclusion Criteria: * Patients Fitzpatrick IV-VI * A recent history of vitiligo, melasma, and other disorders of pigmentation with the exception of post inflammatory hyperpigmentation * Patients with eczema, psoriasis, and contact dermatitis * A known history of photosensitivity disorders * A known history of melanoma or non-melanoma skin cancers * Those planning on going to the tanning parlors * Using any of the photosensitizing medication * A woman who is lactating, pregnant, or planning to become pregnant * Patient planning on exposing the irradiated or control areas to the sun * Patients with organ transplantation, an immunodeficiency disorder or the use of an immunosuppressive drug

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05020496). StuddyBuddy aggregates publicly available trial information.